STOCK TITAN

Bio Essence (BIOE) Stock News

BIOE OTC

Welcome to our dedicated page for Bio Essence news (Ticker: BIOE), a resource for investors and traders seeking the latest updates and insights on Bio Essence stock.

Bio Essence Corp. news covers a wellness-focused operating company that promotes holistic products and practices while pursuing AI-enabled platform initiatives. Company announcements have addressed its OTCQB Venture Market upgrade, Regulation A financing activity, capital-structure matters, material agreements, and governance topics.

Recurring updates for BIOE also describe the company's public-market status and its stated use of growth strategies tied to AI-enabled health platform initiatives and expansion of existing core operations.

Rhea-AI Summary

Bio Essence (OTCQB: BIOE) will acquire the MediFlow AI platform from Zhituo Software for USD $3,500,000, payable in restricted common stock. The Purchased Assets include software source and object code, system architecture, databases, proprietary algorithms, and technical frameworks.

The transaction is expected to close within 45 days, subject to customary conditions and board approval, and aims to expand Bio Essence's personalized digital wellness offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Bio Essence Corp (OTCQB:BIOE) announced approval to upgrade to the OTCQB Venture Market, effective February 26, 2026. The company said the move reflects its commitment to enhanced transparency, regulatory compliance, and widened investor access.

The upgrade is expected to provide increased market visibility, access to real-time Level 2 quotations, and broader exposure while BIOE maintains ongoing OTCQB reporting and verification requirements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Bio Essence Corp (OTC Pink: BIOE) announced a Regulation A, Tier 2 offering to raise up to $5.0 million by selling up to 100,000,000 shares at $0.05 per share, dated February 3, 2026. The company plans to use net proceeds to expand core operations and accelerate its AI-enabled health platform initiatives.

Planned uses include product R&D, branding, an AI-enabled digital health platform (telemedicine, diagnostics, holistic medicine, online classes, personalized nutrition), operations and compliance, and general working capital. Offering documents are available via the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.06%
Tags

FAQ

What is the current stock price of Bio Essence (BIOE)?

The current stock price of Bio Essence (BIOE) is $0.38 as of May 15, 2026.

What is the market cap of Bio Essence (BIOE)?

The market cap of Bio Essence (BIOE) is approximately 14.4M.